IDXX Falls 0.74% as $290M Volume Ranks 437th on 2025-09-17

On September 17, 2025, , . The stock’s performance followed a series of analyst comments and market dynamics specific to the veterinary diagnostics sector.

Recent coverage highlighted mixed sentiment among institutional investors. A note from a prominent acknowledged sustained demand for IDEXX’s companion animal testing platforms but raised concerns over near-term pricing pressures in the U.S. market. Meanwhile, a revealed a slight reduction in Q3 guidance expectations for a key product line, though the company emphasized long-term growth visibility in emerging markets.

of the stock indicated a breakdown below critical support levels established over the preceding three months. Traders noted increased amid broader market uncertainty in healthcare equities, though no direct catalysts such as earnings revisions or partnership announcements were reported for IDXX on the day.

To run a precise back-test I need to pin down a few practical details: 1. Universe—Which market(s) should the stocks come from? 2. Ranking metric—Do we rank by share volume or by notional dollar volume? 3. Portfolio construction—Equal-weight or volume-proportional weight across the 500 names? 4. Execution & hold period—Open the positions at today’s close and exit at tomorrow’s close? If you confirm (or modify) these points I can construct the data-gathering plan and run the back-test.